Back
Bristol-Myers Squibb Stock Price Chart

Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
BMY
Bristol-Myers Squibb
Last Price:
$47.88
Seasonality Move:
2.6%
7 Day Trial
ALL ACCESS PASS
$
7

This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing slight selling pressure.
Bristol-Myers Squibb Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.06 | Sell |
20-day SMA: | 53.01 | Sell |
50-day SMA: | 56.36 | Sell |
200-day SMA: | 53.59 | Sell |
8-day EMA: | 49.37 | Sell |
20-day EMA: | 52.09 | Sell |
50-day EMA: | 55 | Sell |
200-day EMA: | 54.51 | Sell |
Bristol-Myers Squibb Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.7 | Sell |
Relative Strength Index (14 RSI): | 26.55 | Sell |
Chaikin Money Flow: | -859983 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.62 - 59.16) | Sell |
Bollinger Bands (100): | (53.81 - 60.21) | Sell |
Bristol-Myers Squibb Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Bristol-Myers Squibb Stock
Is Bristol-Myers Squibb Stock a Buy?
-
Bristol-Myers Squibb share price is 47.90 while BMY 8-day simple moving average is 49.06, which is a Sell signal.
-
The stock price of BMY is 47.90 while Bristol-Myers Squibb 20-day SMA is 53.01, which makes it a Sell.
-
Bristol-Myers Squibb 50-day simple moving average is 56.36 while BMY share price is 47.90, making it a Sell technically.
-
BMY stock price is 47.90 and Bristol-Myers Squibb 200-day simple moving average is 53.59, creating a Sell signal.
BMY Technical Analysis vs Fundamental Analysis
Sell
28
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy or a Sell?
-
Bristol-Myers Squibb stock is rated a SellThe current Bristol-Myers Squibb [BMY] share price is $47.90. The Score for BMY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Bristol-Myers Squibb Stock Info
Market Cap:
97.5B
Price in USD:
47.90
Share Volume:
16.3M
Bristol-Myers Squibb 52-Week Range
52-Week High:
63.33
52-Week Low:
39.35
Sell
28
Bristol-Myers Squibb (BMY)
is a Sell
Bristol-Myers Squibb Share Price Forecast
-
What is the Bristol-Myers Squibb stock price today?The Bristol-Myers Squibb stock price is 47.90 USD today.
-
Will BMY stock go up or go down?Bristol-Myers Squibb> share price is forecast to RISE/FALL based on technical indicators
-
Is Bristol-Myers Squibb overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bristol-Myers Squibb is overvalued.
Is Bristol-Myers Squibb Stock a Buy?
-
Bristol-Myers Squibb share price is 47.90 while BMY 8-day exponential moving average is 49.37, which is a Sell signal.
-
The stock price of BMY is 47.90 while Bristol-Myers Squibb 20-day EMA is 52.09, which makes it a Sell.
-
Bristol-Myers Squibb 50-day exponential moving average is 55.00 while BMY share price is 47.90, making it a Sell technically.
-
BMY stock price is 47.90 and Bristol-Myers Squibb 200-day simple moving average is 54.51, creating a Sell signal.
Fundamental Analysis of Bristol-Myers Squibb
Is Bristol-Myers Squibb a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.19 per share, an increase this year of $5.94 per share, and a decrease next year of $0.80 per share.
Technical Analysis of Bristol-Myers Squibb
Should I short Bristol-Myers Squibb stock?
-
BMY Moving Average Covergence Divergence (MACD) indicator is -2.7, suggesting Bristol-Myers Squibb is a Sell
-
Bristol-Myers Squibb Relative Strength Index (RSI) is 26.55, which suggest Bristol-Myers Squibb is oversold
-
The Bollinger Bands (25) for Bristol-Myers Squibb is (49.62 - 59.16), which suggest Bristol-Myers Squibb is a Sell
-
The Bollinger Bands (100) for Bristol-Myers Squibb is (53.81 - 60.21), which suggest Bristol-Myers Squibb is a Sell
* Bristol-Myers Squibb stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.